A detailed history of Quest Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Quest Partners LLC holds 1,053 shares of LLY stock, worth $789,665. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,053
Previous 815 29.2%
Holding current value
$789,665
Previous $738 Million 26.43%
% of portfolio
0.08%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $183,769 - $228,484
238 Added 29.2%
1,053 $933 Million
Q2 2024

Aug 06, 2024

SELL
$724.87 - $909.04 $112,354 - $140,901
-155 Reduced 15.98%
815 $738 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $256,422 - $343,057
433 Added 80.63%
970 $755 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $282,027 - $332,472
537 New
537 $313 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.